SEINE BIO · Research, evidence & your next steps
A closer look at cellular energy.
NAD+ plays an essential role in cellular chemistry. Explore why this coenzyme attracts attention in metabolic and healthy-aging research, and what current human studies can tell us about supplied formulations.
This combination is investigational, not an FDA approved treatment.
How NAD+ works
Nicotinamide adenine dinucleotide is a coenzyme involved in redox reactions and cellular processes. It is not a peptide. Endogenous NAD+ biology and the effects of a supplied formulation are separate questions.
Why it’s getting attention
A small human intravenous pilot tracked metabolism during an infusion; newer pilot work examined tolerability. These limited studies do not establish meaningful anti-aging benefit or validate a subcutaneous SEINE BIO pen or cartridge.
Protocol reference at a glance
Reference context, not your prescription. No established patient protocol was identified for this formulation. The chart summarizes research context, not directions for use.
| Stage | What to expect from the evidence |
|---|---|
| Research setting | Human research includes monitored intravenous infusion; not a validated subcutaneous home regimen. |
| Starting / loading phase | No validated routine-care starting or loading dose established for this exact formulation. |
| Standard dose / maximum | No validated standard patient dose or safe maximum established here. |
| Maintenance / cycles | No validated ongoing maintenance or cycling protocol identified. |
Presentation & administration
Intravenous, oral-precursor, nasal and subcutaneous products have different pharmacology. An infusion schedule cannot be converted into a pen schedule, and an oral precursor is not automatically equivalent to NAD+ itself.
Catalog presentation: Vial / Cartridge / Disposable Injection Pen. Listed strength options: 500 mg; 1000 mg. One catalog unit is one selected presentation—not a box containing every pictured format. Total container content is not a personal dose, and an illustration does not verify an approved route or device.
Risks & common side effects
- A reliable adverse-effect profile for this exact catalog formulation is not established. Infusion tolerability findings cannot define the safety of another route or concentration.
- Persistent fatigue should be assessed for medical, sleep, nutritional or medication-related causes. Do not combine experimental products to treat an unexplained symptom.
Tell your clinician about new or persistent symptoms and other medicines. Changes to treatment should be clinician-directed.
Other options worth discussing
Investigate the cause of low energy first, then address sleep, nutrition, activity, confirmed deficiencies or diagnosed disease with an established plan. “More established” does not mean risk-free or suitable for everyone; a clinician should compare benefits, contraindications and your preferences.
When to seek help
Chest discomfort, breathing difficulty, fainting or persistent unexpected symptoms require medical review.
Finished-product quality, concentration and route require verification. Review allergies, pregnancy, health conditions and other medicines with your clinician.
Do not wait for a portal reply in an emergency. Call 911 or seek emergency care for severe or rapidly worsening symptoms.
A few useful answers
Does NAD+ being essential mean extra NAD+ will boost energy?
No. Essential endogenous biology does not demonstrate a clinical benefit from a supplied product.
Is this equivalent to an NAD+ infusion?
Not established. Route, concentration, formulation and monitoring differ.
Does clinician authorization guarantee access?
No. Clinical appropriateness, lawful availability and a verified finished formulation must each be established. An Rx setting, luxury image or research-series label does not create regulatory approval.
Research & references
General information, not a prescription or a guarantee of results. Research and reference-label schedules do not replace instructions for your exact prescribed product. Clinical suitability and lawful availability require separate confirmation.
Make your next step an informed one.
Share what you want to improve, what you have already tried, and the questions you have about NAD+. Your care team can help put the evidence and alternatives in context.
Sign-in may be required. This is not an emergency service or a guarantee that this product is available.
Product codes & historical records
Historical catalog reference
Source snapshot captured October 11, 2026. Historical catalog reference only; this draft is unavailable for purchase. Supplier prices, packaging, stock and reported test content describe the archived source entries, not a current SEINE BIO supply lot.
NAD+ — 450 mg per vial
Product Code: 6500-501
Original supplier title: 6500 Buffered (10*450mg) 5ml
| Supplier | Supplier |
|---|---|
| Supplier pack | 10 vials |
| Nominal content | 450 mg per vial |
| Source listed price (USD) | $60.00 per supplier pack |
| Source regular price (USD) | $90.00 per supplier pack |
| Source price per unit (USD) | $6.00 (arithmetic reference) |
| Batch shown on product page | 2026056500 |
| Source stock snapshot | 14 in stock — US warehouse |
| Source weight | 0.179 lbs |
| Source dimensions | 4.53 × 1.89 × 2.24 in |
Archived supplier description: Supplier description states NAD 500 mg in a 5 mL container, tested content of 464 mg, a $60 price, and website code 6500.
Source discrepancies / additional details: Title states 450 mg; description and code table state 500 mg; supplier reports tested 464 mg. 5 mL container.
NAD+ — 500 mg per vial
Product Code: 6500
Original supplier title: 6500 Buffered (10*500mg) 10ml
| Supplier | Supplier |
|---|---|
| Supplier pack | 10 vials |
| Nominal content | 500 mg per vial |
| Source listed price (USD) | $70.00 per supplier pack |
| Source regular price (USD) | $100.00 per supplier pack |
| Source price per unit (USD) | $7.00 (arithmetic reference) |
| Batch shown on product page | 2026076500 |
| Source stock snapshot | 314 in stock — US warehouses |
| Source weight | 0.227 lbs |
| Source dimensions | 4.53 × 1.89 × 2.24 in |
Archived supplier description: Supplier reports tested content of 540 mg.
Source discrepancies / additional details: Supplier description reports tested 540 mg. 10 mL container.







